A multiple outcome model to assess cost-effectiveness: Results from the Emory Angioplasty versus Surgery Trial (EAST)

被引：0

作者：

Mauldin, PD

Weintraub, WS

Jeong, JO

Becker, ER

机构：

[1] Med Univ S Carolina, Dept Biometry & Epidemiol, Charleston, SC USA

[2] Emory Univ, Dept Med, Atlanta, GA 30322 USA

[3] Ajou Univ, Dept Econ, Suwon 441749, South Korea

[4] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA

[5] Med Univ S Carolina, Clin Innovat Grp, Charleston, SC USA

来源：

BIOMETRICAL JOURNAL | 1999年 / 41卷 / 01期

关键词：

multiple outcomes; cost-effectiveness; randomized clinical trials; coronary artery disease;

D O I：

10.1002/(SICI)1521-4036(199903)41:1<3::AID-BIMJ3>3.0.CO;2-S

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

This paper is an empirical analysis comparing coronary angioplasty (PTCA) to coronary artery bypass surgery (CABG) as an initial form of therapy for patients with multivessel coronary artery disease. The paper presents a model which relates multiple patient descriptors to multiple patient outcomes for 392 randomized patients to determine which procedure offers more units of quality health increase per unit increase in cost (proxy for resource utilization). The results indicate that at three year follow-up, there is no difference in cost-effectiveness between the two alternative therapies.

引用

页码：3 / 23

页数：21

共 50 条

[21] THE INCREMENTAL COST-EFFECTIVENESS OF CORONARY STENTING VERSUS CONVENTIONAL ANGIOPLASTY - A DECISION-ANALYTIC MODEL
COHEN, DJ
KUNTZ, RE
BREALL, JA
HO, KKL
GOLDMAN, L
WEINSTEIN, MC
BAIM, DS
CIRCULATION, 1992, 86 (04) : 40 - 40
[22] COST-EFFECTIVENESS OF PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY VERSUS VASCULAR-SURGERY FOR LIMB-THREATENING ISCHEMIA
LAURILA, JM
RADIOLOGY, 1995, 197 : 233 - 233
[23] Cost and cost-effectiveness of intravenous enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention: Results from the STEEPLE trial
Zhao, Liping
Ewen, Edward
Zhang, Zefeng
Bowen, James
Jurkovitz, Claudine
Leguet, Prisca
Kolm, Paul
Weintraub, William S.
CIRCULATION, 2006, 114 (18) : 827 - 827
[24] Potential cost-effectiveness of intracoronary stent versus angioplasty in coronary artery disease. A Markov model
Nichol, G
Juergenson, L
Higginson, LA
Labinaz, M
Hendry, P
Marquis, JF
CIRCULATION, 1997, 96 (08) : 1899 - 1899
[25] Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial)
Gomes, M.
Soares, M. O.
Dumville, J. C.
Lewis, S. C.
Torgerson, D. J.
Bodenham, A. R.
Gough, M. J.
Warlow, C. P.
BRITISH JOURNAL OF SURGERY, 2010, 97 (08) : 1218 - 1225
[26] COST-EFFECTIVENESS OF CHEMOPREVENTION WITH DUTASTERIDE BASED ON RESULTS FROM THE REDUCE CLINICAL TRIAL
Earnshaw, S. R.
McDade, C. L.
Black, L.
Kattan, M. W.
VALUE IN HEALTH, 2009, 12 (07) : A271 - A271
[27] Surgery versus Imaging in Non-Localizing Primary Hyperparathyroidism: A Cost-Effectiveness Model
Frank, Ethan
Watson, WayAnne
Fujimoto, Shannon
De Andrade Filho, Pedro
Inman, Jared
Simental, Alfred
LARYNGOSCOPE, 2020, 130 (12): : E963 - E969
[28] Cost-effectiveness of migraine prevention: Results from a model of topiramate treatment
Brown, JS
Papadopoulos, G
Neumann, PJ
Friedman, M
Menzin, J
VALUE IN HEALTH, 2004, 7 (03) : 237 - 237
[29] Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial
Michaud, Tzeyu L.
Wilson, Kathryn E.
Katula, Jeffrey A.
You, Wen
Estabrooks, Paul A.
TRANSLATIONAL BEHAVIORAL MEDICINE, 2023, 13 (07) : 501 - 510
[30] Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial
Kaku, Kohei
Haneda, Masakazu
Sakamaki, Hiroyuki
Yasui, Atsutaka
Murata, Tatsunori
Ustyugova, Anastasia
Chin, Rina
Hirase, Tetsuaki
Shibahara, Tsunehisa
Hayashi, Naoyuki
Kansal, Anuraag
Kaspers, Stefan
Okamura, Tomoo
CLINICAL THERAPEUTICS, 2019, 41 (10) : 2021 - 2040

← 1 2 3 4 5 →